Published in Res Microbiol on February 01, 1997
Borrelia burgdorferi erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun (1998) 2.67
Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res (2004) 1.96
Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A (1997) 1.50
Comparative genome analysis: selection pressure on the Borrelia vls cassettes is essential for infectivity. BMC Genomics (2006) 1.47
Relapsing fever spirochetes retain infectivity after prolonged in vitro cultivation. Vector Borne Zoonotic Dis (2008) 1.01
Dynamics of dissemination and outer surface protein expression of different European Borrelia burgdorferi sensu lato strains in artificially infected Ixodes ricinus nymphs. J Clin Microbiol (2002) 0.94
The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13. J Bacteriol (2006) 0.86
Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients. J Clin Microbiol (2005) 0.81
Borrelia burgdorferi linear plasmid 28-3 confers a selective advantage in an experimental mouse-tick infection model. Infect Immun (2013) 0.77
Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 5.06
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun (1993) 4.16
An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol (1993) 3.64
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Mol Microbiol (1992) 3.45
Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection (1993) 2.89
Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc Natl Acad Sci U S A (1993) 2.77
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.43
Lyme borreliosis: basic science and clinical aspects. Lancet (1994) 2.19
The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology (2005) 2.13
Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res (2004) 1.96
Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Med Microbiol Immunol (1993) 1.89
Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun (1997) 1.79
Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (1996) 1.70
Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. J Clin Microbiol (1995) 1.67
Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol (1984) 1.64
Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection (1990) 1.61
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus. J Clin Microbiol (1995) 1.60
Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med Microbiol Immunol (1994) 1.56
Severe diarrhea associated with Arcobacter butzleri. Eur J Clin Microbiol Infect Dis (1994) 1.52
Lyme disease presenting as Tourette's syndrome. Lancet (1998) 1.50
Blood loss in the Kolff twin-coil artificial kidney. Nephron (1970) 1.50
Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J Clin Microbiol (1999) 1.49
Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol (1997) 1.45
Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis (1986) 1.45
Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype. J Clin Microbiol (1995) 1.44
Serological diagnosis of erythema migrans disease and related disorders. Infection (1985) 1.42
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
[Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis]. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.38
Cross-reactive proteins of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1992) 1.36
In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur J Clin Microbiol (1987) 1.36
The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome). J Neurol (1984) 1.34
Clinical evaluation of a recombinant hepatitis B vaccine. Lancet (1984) 1.33
Antigenic heterogeneity of European Borrelia burgdorferi strains isolated from patients and ticks. Lancet (1985) 1.33
An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (2003) 1.33
Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species. Med Microbiol Immunol (1995) 1.32
Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med Microbiol Immunol (1992) 1.32
Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol (1999) 1.26
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (1993) 1.25
Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection (1996) 1.24
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1989) 1.24
Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol (1996) 1.19
Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis. J Clin Microbiol (1997) 1.18
Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland. J Clin Microbiol (2002) 1.17
A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol (2000) 1.17
Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis (1991) 1.15
Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field. J Clin Microbiol (2001) 1.15
Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains. Med Microbiol Immunol (1992) 1.13
Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease. Infection (1991) 1.13
Molecular polymorphism of the lyme disease agent Borrelia garinii in northern Europe is influenced by a novel enzootic Borrelia focus in the North Atlantic. J Clin Microbiol (1996) 1.12
Taxonomy of Borrelia spp. Scand J Infect Dis Suppl (1991) 1.11
European erythema migrans disease and related disorders. Yale J Biol Med (1985) 1.11
Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol (1998) 1.11
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med Microbiol Immunol (1998) 1.10
Reinfection with Borrelia burgdorferi. Lancet (1986) 1.10
Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity. J Clin Microbiol (1999) 1.10
Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol (1998) 1.06
Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis (1991) 1.06
[Clinical aspects and etiology of acrodermatitis chronica atrophicans]. Hautarzt (1984) 1.06
Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent. J Infect Dis (2001) 1.05
Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05
Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany. Med Microbiol Immunol (1999) 1.05
Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant. J Med Microbiol (2000) 1.02
Myositis caused by Borrelia burgdorferi: report of four cases. J Neurol Sci (1989) 1.01
Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology (1989) 1.01
Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol (1998) 1.01
Iron absorption in rheumatoid arthritis. Ann Rheum Dis (1969) 1.01
Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection (1996) 1.00
Comparison of OspA serotypes for Borrelia burgdorferi sensu lato from Japan, Europe and North America. Microbiol Immunol (1996) 1.00
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain (2001) 0.99
Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis. Scand J Infect Dis (1996) 0.97